Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 22 06 2021
accepted: 09 07 2021
pubmed: 14 7 2021
medline: 28 10 2021
entrez: 13 7 2021
Statut: ppublish

Résumé

Post recovery manifestations have become another concern in patients who have recovered from coronavirus disease 2019 (COVID-19). Numerous reports have shown that COVID-19 has a variety of long-term effects on almost all systems including respiratory, cardiovascular, gastrointestinal, neurological, psychiatric, and dermatological systems. We aimed to investigate the prevalence and characteristics of the post-COVID syndrome among COVID-19 survivors and to determine the factors associated with persistent symptoms. This prospective study enrolled in patients with COVID-19 followed in hospital or outpatient clinics in Ankara City Hospital. We performed a special questionnaire to inquire about the presence of persistent symptoms beyond 12 weeks from the first diagnosis. Demographic data, comorbid diseases, characteristics of acute COVID-19, presence of persistent symptoms by systems, and knowledge about outpatient clinic visits after recovery were assessed. Of a total of 1007 participants, 39.0% had at least one comorbidity, and 47.5% had persistent symptoms. Fatigue/easy fatigability, myalgia, and loss of weight were the most frequent persistent symptoms (overall 29.3%) followed by respiratory symptoms (25.4%). A total of 235 participants had visited outpatient clinics due to several reasons during the post-COVID-19 period, and 17 of them were hospitalized. Severe acute COVID-19, hospitalization, and presence of comorbidity were independent factors for the development of persistent symptoms. Fully understanding the spectrum of the post-COVID syndrome is essential for appropriate management of all its long-term effects. Our study once again underlined the fact that the prevalence of post-COVID syndrome is higher than expected and concerns many systems, and a multidisciplinary follow-up should be provided to COVID-19 survivors in the post recovery period.

Identifiants

pubmed: 34255355
doi: 10.1002/jmv.27198
pmc: PMC8426910
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6566-6574

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875
pubmed: 33892403
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
J Med Virol. 2021 Dec;93(12):6566-6574
pubmed: 34255355
BMJ. 2021 Mar 31;372:n693
pubmed: 33789877
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Int J Clin Pract. 2021 Mar;75(3):e13746
pubmed: 32991035
Open Forum Infect Dis. 2021 Jan 29;8(4):ofab042
pubmed: 33875970
J Med Virol. 2021 May;93(5):2555-2556
pubmed: 33095459
J Infect. 2021 Mar;82(3):378-383
pubmed: 33450302
Int J Environ Res Public Health. 2021 Mar 05;18(5):
pubmed: 33807869
Clin Microbiol Infect. 2021 Feb;27(2):258-263
pubmed: 33031948
BMC Infect Dis. 2021 Mar 25;21(1):304
pubmed: 33765941
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
BMJ. 2020 Dec 23;371:m4938
pubmed: 33361141
Psychiatry Res. 2021 Jan;295:113599
pubmed: 33285346
JAMA. 2020 Dec 8;324(22):2251-2252
pubmed: 33206133
PLoS One. 2021 Apr 8;16(4):e0249644
pubmed: 33831043
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238

Auteurs

Bircan Kayaaslan (B)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.

Fatma Eser (F)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.

Ayse K Kalem (AK)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.

Gamze Kaya (G)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Betul Kaplan (B)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Duygu Kacar (D)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Imran Hasanoglu (I)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.

Belgin Coskun (B)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Rahmet Guner (R)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH